Winship treats first lung cancer patient with T-cell receptor

Frontiers Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects

Articles and Media Releases - Archive

Spring/Summer 2020 Emory Health Digest

Cancers, Free Full-Text

Clinical Updates in Non-Small Cell Lung Cancer from Madrid - A Clinical Updates Activity - Integrity CE

Articles and Media Releases - Archive

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Frontiers Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects

Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment - ScienceDirect

History of Winship Winship Cancer Institute

As National Cancer Act turns 50, Winship Cancer Institute reflects on progress

History of Winship Winship Cancer Institute

How Science Became Hope 50th Anniversary of the National Cancer Act